In a commentary, published in The Lancet Gastroenterology & Hepatology, frontline voices reveal how recent global health funding cuts are already disrupting hepatitis B and C services worldwide. More
The C-Free study concludes that community-based HCV treatment of people who use drugs in Thailand, within harm reduction settings, is safe and effective. More
One in nine people in prisons globally have a history of injecting drug use and their risk of HIV, viral hepatitis and TB is up to 45 times higher than in the general population. More
Scaling up needle and syringe programmes is essential for achieving global infectious disease-elimination goals and improving health outcomes among people who inject drugs. More
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the R&D pipeline. More
